Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dana Pe'er, Heidi Rehm, Geoffrey Ginsburg, Thomas Quertermous, and Mark Yandell


The International Society for Computational Biology has awarded this year's Overton Prize to Dana Pe'er, an associate professor in the biological sciences and systems biology department at Columbia University in New York, NY.

Pe'er will be a keynote speaker at this year's Intelligent Systems for Molecular Biology conference in Boston, Mass. and will present a talk titled “A Multidimensional Single Cell Approach to Understand Cellular Behavior” on July 14, 2014. She received her bachelor's degree in mathematics and her master's and doctoral degrees in computer science from the Hebrew University of Jerusalem.

The annual Overton prize — established in memory of G. Christian Overton, a computational biologist and founding ISCB Board member who passed away unexpectedly in 2000 — recognizes independent scientists in the early or middle phases of their careers for their significant contributions to computational biology through research, teaching, and service.

Omicia has added four new members to its scientific advisory board.

They are Heidi Rehm, director of the laboratory for molecular medicine at Partners Healthcare Personalized Medicine and an associate professor of pathology at Harvard Medical School.

Geoffrey Ginsburg, director of genomic medicine of the Duke Institute for Genome Sciences & Policy and executive director of the Center for Personalized Medicine and Precision at Duke Medicine where he is also a professor of medicine and biomedical engineering.

Thomas Quertermous, a professor of medicine and director of research for the division of cardiovascular medicine at Stanford University.

And Mark Yandell, a professor of human genetics at the University of Utah, and co-director of the USTAR Center for Genetic Discovery. He is also a co-inventor of Omicia’s VAAST and newly-released Phevor algorithms.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.